These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 39044608)
1. Acute nicotinamide riboside supplementation increases human cerebral NAD Nanga RPR; Wiers CE; Elliott MA; Wilson NE; Liu F; Cao Q; Swago S; Jacobs PS; Armbruster R; Reddy D; Baur JA; Witschey WR; Detre JA; Reddy R Magn Reson Med; 2024 Dec; 92(6):2284-2293. PubMed ID: 39044608 [TBL] [Abstract][Full Text] [Related]
2. Identification of new resonances in downfield Nanga RPR; Elliott MA; Swain A; Wilson NE; Swago S; Witschey WR; Reddy R Magn Reson Med; 2023 Sep; 90(3):1166-1171. PubMed ID: 37125620 [TBL] [Abstract][Full Text] [Related]
3. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Remie CME; Roumans KHM; Moonen MPB; Connell NJ; Havekes B; Mevenkamp J; Lindeboom L; de Wit VHW; van de Weijer T; Aarts SABM; Lutgens E; Schomakers BV; Elfrink HL; Zapata-Pérez R; Houtkooper RH; Auwerx J; Hoeks J; Schrauwen-Hinderling VB; Phielix E; Schrauwen P Am J Clin Nutr; 2020 Aug; 112(2):413-426. PubMed ID: 32320006 [TBL] [Abstract][Full Text] [Related]
4. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Brakedal B; Dölle C; Riemer F; Ma Y; Nido GS; Skeie GO; Craven AR; Schwarzlmüller T; Brekke N; Diab J; Sverkeli L; Skjeie V; Varhaug K; Tysnes OB; Peng S; Haugarvoll K; Ziegler M; Grüner R; Eidelberg D; Tzoulis C Cell Metab; 2022 Mar; 34(3):396-407.e6. PubMed ID: 35235774 [TBL] [Abstract][Full Text] [Related]
5. Single-Voxel Bagga P; Hariharan H; Wilson NE; Beer JC; Shinohara RT; Elliott MA; Baur JA; Marincola FM; Witschey WR; Haris M; Detre JA; Reddy R Magn Reson Med; 2020 Mar; 83(3):806-814. PubMed ID: 31502710 [TBL] [Abstract][Full Text] [Related]
6. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. Airhart SE; Shireman LM; Risler LJ; Anderson GD; Nagana Gowda GA; Raftery D; Tian R; Shen DD; O'Brien KD PLoS One; 2017; 12(12):e0186459. PubMed ID: 29211728 [TBL] [Abstract][Full Text] [Related]
7. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise. Stocks B; Ashcroft SP; Joanisse S; Dansereau LC; Koay YC; Elhassan YS; Lavery GG; Quek LE; O'Sullivan JF; Philp AM; Wallis GA; Philp A J Physiol; 2021 Mar; 599(5):1513-1531. PubMed ID: 33492681 [TBL] [Abstract][Full Text] [Related]
8. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men. Dollerup OL; Chubanava S; Agerholm M; Søndergård SD; Altıntaş A; Møller AB; Høyer KF; Ringgaard S; Stødkilde-Jørgensen H; Lavery GG; Barrès R; Larsen S; Prats C; Jessen N; Treebak JT J Physiol; 2020 Feb; 598(4):731-754. PubMed ID: 31710095 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice. Kim MB; Pham TX; vanLuling M; Kostour V; Kang H; Corvino O; Jang H; Odell W; Bae M; Park YK; Lee JY J Nutr Biochem; 2022 Sep; 107():109058. PubMed ID: 35643283 [TBL] [Abstract][Full Text] [Related]
10. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis. Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117 [TBL] [Abstract][Full Text] [Related]
11. Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells. Kropotov A; Kulikova V; Nerinovski K; Yakimov A; Svetlova M; Solovjeva L; Sudnitsyna J; Migaud ME; Khodorkovskiy M; Ziegler M; Nikiforov A Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573263 [TBL] [Abstract][Full Text] [Related]
13. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction. Kahn B; Borrelli M; Libby T J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044 [TBL] [Abstract][Full Text] [Related]
14. Purine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells. Kropotov A; Kulikova V; Solovjeva L; Yakimov A; Nerinovski K; Svetlova M; Sudnitsyna J; Plusnina A; Antipova M; Khodorkovskiy M; Migaud ME; Gambaryan S; Ziegler M; Nikiforov A J Biol Chem; 2022 Dec; 298(12):102615. PubMed ID: 36265580 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide riboside alleviates brain dysfunction induced by chronic cerebral hypoperfusion via protecting mitochondria. Wang L; Peng T; Deng J; Gao W; Wang H; Junhong Luo O; Huang L; Chen G Biochem Pharmacol; 2024 Jul; 225():116272. PubMed ID: 38723719 [TBL] [Abstract][Full Text] [Related]
16. Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk. Trammell SA; Yu L; Redpath P; Migaud ME; Brenner C J Nutr; 2016 May; 146(5):957-63. PubMed ID: 27052539 [TBL] [Abstract][Full Text] [Related]
17. Nicotinamide Riboside Enhances Mitochondrial Proteostasis and Adult Neurogenesis through Activation of Mitochondrial Unfolded Protein Response Signaling in the Brain of ALS SOD1 Zhou Q; Zhu L; Qiu W; Liu Y; Yang F; Chen W; Xu R Int J Biol Sci; 2020; 16(2):284-297. PubMed ID: 31929756 [TBL] [Abstract][Full Text] [Related]
18. What is really known about the effects of nicotinamide riboside supplementation in humans. Damgaard MV; Treebak JT Sci Adv; 2023 Jul; 9(29):eadi4862. PubMed ID: 37478182 [TBL] [Abstract][Full Text] [Related]
19. Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm. Marinescu AG; Chen J; Holmes HE; Guarente L; Mendes O; Morris M; Dellinger RW Int J Toxicol; 2020; 39(4):307-320. PubMed ID: 32715855 [TBL] [Abstract][Full Text] [Related]